retatrutide dosing phase 2 trial results Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people A Study of Retatrutide (LY3437943)
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31







,aspect=ignore)




















